Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 27, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 27, 2018Completed
Condition(s):Brain and Central Nervous System Tumors; Metastatic CancerLast Updated:November 6, 2013Unknown status
Condition(s):Brain and Central Nervous System TumorsLast Updated:February 4, 2013Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 20, 2013Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 5, 2015Withdrawn
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 27, 2018Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 3, 2013Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 22, 2014Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:February 9, 2009Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:April 5, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.